Under this agreement Apollo Healthcare will provide its Prior-Authorization package, amongst other services to ART’s existing customer base, as well as any healthcare facilities considering use of their products such as PreciseRT and AccuBoost for adoption within their clinical patient treatment armamentariums.

October 21, 2021 — Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have announced a strategic partnership aimed at easing the challenge radiation oncology clinics have in pre-authorizing patients for insurance coverage for innovative radiation cancer therapies. Under this agreement Apollo Healthcare will provide its Prior-Authorization package, amongst other services to ART’s existing customer base, as well as any healthcare facilities considering use of their products such as PreciseRT and AccuBoost for adoption within their clinical patient treatment armamentariums. 

“We are very excited to be teaming with Apollo Healthcare to ensure oncology patients that can benefit from PreciseRT and AccuBoost are able to receive our novel Non-Invasive Breast Brachytherapy (NIBB) treatments with no delay or interruption to care based on insurance coverage.” remarked Bill Dowd, Chief Executive Officer of Advanced Radiation Therapy, LLC.

By leveraging the human resources, financial modeling and intimate knowledge of commercial and Medicare insurance coding and payment coverage provided by Apollo Healthcare a U.S. based healthcare facility can be sure that physicians will be able to treat patients with the technology of their choice and that the health care facility will be paid the appropriate payment for the lifesaving care the center provides each cancer patient. 

“Apollo Healthcare is ready to serve as an additional resource to clinics utilizing ART’s products and technology. We are a team of experienced oncology administrative and clinical veterans who relish the opportunity to wade through the details to get to the core problem of preauthorization delays and payment denials ensuring that physicians can utilize the best technology for their patients’ needs and the health care facilities in which they practice will equitably be paid for the care they deliver,” Christopher Gonzalez, Co-founder of Apollo commented. ART will be showcasing this new partnership at the upcoming American Society of Therapeutic Radiation Oncologists (ASTRO) annual meeting in Chicago, Illinois from October 24-27. 2021.

For more information: www.apollohealthcare.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Remanufactured Refurbished Equipment

Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...

Time January 23, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
Subscribe Now